Tetrahydrocannabinol (THC) is the major psychoactive constituent of marijuana. It is well known that D 8 -THC is oxidized to numerous metabolites in the liver of various mammals including monkeys and humans.
-THC is oxidized to numerous metabolites in the liver of various mammals including monkeys and humans. 1, 2) Most metabolites have been suggested to contribute to the psychoactivity of the parent compound. 7-Oxo-D 8 -THC shows almost equivalent pharmacological activity to D 8 -THC in mice, whereas 7a-and 7b-hydroxy-D 8 -THC (7a-and 7b-OH-D 8 -THC) were without significant activity.
3) Several recent studies have clarified that cytochrome P450 (P450) plays a major role in the oxidation of THC. [4] [5] [6] [7] [8] However, the metabolic reaction is complicated and the isoforms responsible for specific metabolic reactions have not been completely elucidated. We have previously found that a guinea pig hepatic microsomal enzyme, called microsomal alcohol oxygenase (MALCO), is able to oxidize 7-OH-D 8 -THC to 7-Oxo-D 8 -THC (Fig. 1 ), 9) and have recently clarified that P450 isoforms belonging to the 3A subfamily are the major enzymes of 7-OH-D 8 -THC MALCO in guinea pigs (P450GPF-B), 10) mice (CYP3A11), 11) rats (CYP3A1 and CYP3A2), 12) and humans (CYP3A4). 13) CYP3A is a highly expressed enzyme in rodents, monkeys, and humans and it has been demonstrated to play a prominent role in the metabolism of many clinically important drugs. 14) CYP3A shows selectivity for the chemical substituents rather than selectivity for substrates. 15, 16) For example, the allylic positions, in spite of structurally unrelated compounds, are the major site of oxidation catalyzed by CYP3A. [17] [18] [19] [20] Species-related differences exist in the catalytic properties of P450 enzymes belonging to the same family or subfamily, but it is difficult to elucidate the properties of the enzyme responsible for a specific reaction across species. 12, 21) To our best knowledge, no detailed study has been reported with respect to the specific isoform(s) involved in the formation of 7-oxo-D 8 -THC from 7a-and 7b-OH-D 8 -THC in monkeys.
In the present study, we purified a P450 enzyme catalyzing the stereoselective oxidation of 7a-and 7b-OH-D 8 -THC to 7-Oxo-D 8 -THC from hepatic microsomes of Japanese monkeys and considered the oxidation mechanisms of 7-OH-D 8 -THC and 8-OH-D   9 -THC using oxygen-18 gas.
MATERIALS AND METHODS
Materials Sepharose 4B and 2Ј,5Ј-ADP-Sepharose 4B were from Pharmacia Fine Chemicals (Uppsala, Sweden); hydroxylapatite for an open column was from Bio-Rad (Richmond, CA, U.S.A.); preparative DEAE-5PW and hydroxylapatite columns for HPLC were from Tosoh (Tokyo, Japan), 18 patic microsomes with chloroform-methanol (2 : 1) and the solvent was evaporated to dryness in vacuo. Other chemicals and solvents used were of the highest quality commercially available.
Animals and Preparation of Microsomes Liver samples from male (6-year-old) rhesus monkey were provided by Osaka Bioscience Institute (Suita, Japan), and female (9-year-old) rhesus monkey, and male (2-and 6-year-old) and female (7-and 10-year-old) Japanese monkeys were provided by the Primate Research Institute, Kyoto University (Inuyama, Japan). The liver samples homogenized with a Teflonhomogenizer were centrifuged to obtain the microsomes as descrived previously. 25) The microsomal pellets obtained were suspended in 100 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol and 5 mM EDTA.
Inhibition of Metabolic Activity by Antibody
The antibody was added to medium containing microsomes and 100 mM potassium phosphate buffer (pH 7.4), and then preincubated at 37°C for 30 min. The NADPH-generating system (0.5 mM NADP, 10 mM glucose 6-phosphate, 1 unit of glucose-6-phosphate dehydrogenase and 10 mM magnesium chloride) was added to the medium, and substrate added to start the reaction. After incubation at 37°C for 20 min, the metabolites were assayed by the same methods described previously. 10) Purification of P450 from Hepatic Microsomes of (7-and 10-Year-Old) Female Japanese Monkeys Microsomes were suspended in buffer A [0.1 M potassium phosphate buffer (pH 7.2) containing 20% glycerol, 1 mM EDTA, and 0.5 mM dithiothreitol]. Then 20% sodium cholate solution (pH 7.4) was added to a final concentration of 0.7%. This mixture was stirred for 30 min at 4°C to solubilize microsomes and the resulting suspension was centrifuged at 105000ϫg for 60 min.
The supernatant fraction of the cholate-solubilized hepatic microsomes was put on an w-aminooctyl-Sepharose 4B column (4ϫ30 cm) equilibrated with buffer A containing 0.5% sodium cholate. The column was washed with the equilibration buffer, and P450 was eluted with buffer A containing 0.4% sodium cholate and 0.1% Emulgen 911. The P450 fractions were pooled, concentrated with an ultrafiltration membrane (UK-50, Toyo Roshi, Tokyo, Japan), and dialyzed against 20 mM Tris-acetate buffer (pH 7.5) containing 20% glycerol. The dialyzed solution was subjected to HPLC with a preparative DEAE-5PW anion-exchange column (2.15ϫ15 cm), previously equilibrated with buffer B [20 mM Tris-acetate buffer (pH 7.5) containing 20% glycerol and 0.4% Emulgen 911]. The column chromatography was performed with a linear gradient of sodium acetate from 0 to 0.2 M in buffer B. The elution profiles of heme and protein were monitored at 417 and 244 nm, respectively, as described by Funae and Imaoka.
26)
The immunologically reactive fractions with antibody against P450GPF-B were dialyzed against buffer C [10 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol and 0.2% sodium cholate] and subjected to HPLC with a hydroxylapatite column, previously equilibrated with buffer C. P450 was eluted with a linear gradient of potassium phosphate buffer (pH 7.4) from 10 to 350 mM containing 20% glycerol, 0.2% sodium cholate, and 0.4% Emulgen 911. The fractions eluted with 125 to 185 mM potassium phosphate buffer were combined and concentrated by ultrafiltration. After dialysis against buffer D [5 mM potassium phosphate buffer (pH 7.25) containing 20% glycerol, 1 mM EDTA, 0.1 mM dithiothreitol, and 0.4% Emulgen 911], the solution was applied to a CM-Sephadex C-50 column (1.2ϫ30 cm), previously equilibrated with buffer D. P450 was eluted with 100 ml each of buffer D containing 5, 10, 20, 40, 80, or 160 mM potassium phosphate buffer. The fractions eluted with the 20 and 40 mM phosphate buffers were separately concentrated and dialyzed against buffer C. The dialyzed samples were subjected to HPLC with a hydroxylapatite column (0.75ϫ7 cm) again, previously equilibrated with buffer C. P450 was eluted with a linear gradient of potassium phosphate buffer (pH 7.4) from 10 to 350 mM containing 20% glycerol, 0.2% sodium cholate, and 0.4% Emulgen 911. The fractions eluted with approximately 150 mM potassium phosphate buffer were electrophoretically homogeneous. The detergent was removed by using a small hydroxylapatite column as previously described. 6) Purification of Other Enzymes NADPH-cytochrome c (P450) reductase and cytochrome b 5 were purified from hepatic microsomes of male ddY mice (Hokuriku Experimental Animals Laboratory, Kanazawa, Japan) by the methods of Yasukochi and Masters, 27) and Funae and Imaoka, 26) respectively. One unit of the reductase was defined as the amount of reductase catalyzing the reduction of 1 mmol of cytochrome Measurement of Oxidative Activity The formation of 7-Oxo-D 8 -THC was measured as previously described, 10) except for the conditions in the reconstitution studies described below. 7-OH-D 8 -THC (12 mg) or 8-OH-D 9 -THC (12 mg) was incubated with purified P450 (25 pmol), 0.15 units of NADPH-cytochrome c (P450) reductase, 25 pmol of cytochrome b 5 , 20 mg of microsomal lipids, 100 mg of sodium cholate, 1 mM NADPH, and 100 mM potassium phosphate buffer (pH 7.4) to make a final volume of 0.5 ml. The mixture was incubated at 37°C for 20 min after preincubation at 37°C for 2 min. Metabolites were extracted with ethyl acetate and analyzed by electron capture detector-gas chromatography or gas chromatography-mass spectrometry (GC-MS) as described previously. 10) The isotopic incorporation values were calculated using the following equation, where A was the ratio in relative intensities of ions at [ -THC under air, and C was atom % of 18 O 2 :
The oxidative metabolism of testosterone was determined as described previously.
10)
Other Methods Polyclonal antibody against the purified P450 was raised in rabbits, and the IgG fraction from the serum was obtained by the previously reported method. 4, 28) Western blotting was performed as described previously. 29) Protein concentration was estimated by the method of Lowry et al., 30) using bovine serum albumin as a standard. P450 and cytochrome b 5 contents were determined by the methods of Omura and Sato, 31) and Omura and Takesue, 32) respectively. w-Aminooctyl-Sepharose 4B was prepared as described previously. 33) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out according to the method of Laemmli. Table 1 shows the enzyme activities for the formation of 7-Oxo-D 8 -THC from 7a-and 7b-OH-D 8 -THC in hepatic microsomes of monkeys. There is no significant difference in the MALCO activities between male and female monkeys. The activity was stereoselective and the rate of conversion to 7-Oxo-D 8 -THC from 7b-OH-D 8 -THC was 2.5-to 4.6-fold higher than that from 7a-OH-D 8 -THC.
34) RESULTS

7-OH-D D 8 -THC MALCO Activity in Monkey Liver
Effects of Antibody against P450GPF-B on 7-OH-D D
8 -THC MALCO Activity and Microsomal Testosterone Oxidation Addition of the antibody against P450GPF-B to the incubation medium caused a dose-dependent suppression of the activities of both 7a-and 7b-OH-D 8 -THC MALCO in monkey liver (Fig. 2) . When the anti-P450GPF-B IgG was added to a 3-fold amount of the microsomal protein, the MALCO activities were suppressed to about 35 and 10%, respectively, of the control values. The antibody also inhibited testosterone 6b-hydroxylation in the hepatic microsomes in the same manner as MALCO activity for 7-OH-D 8 -THC, especially the b-epimer (Fig. 2) . Purification of P450 from Hepatic Microsomes of Japanese Monkeys On the basis of the above results, we carried out the purification of MALCO from hepatic microsomes of Japanese monkeys using the immunological crossreaction with antibody against P450GPF-B as an indicator. The P450-containing fraction was eluted as one peak by washing the w-aminooctyl-Sepharose 4B column with phosphate buffer (pH 7.25) containing 0.1% Emulgen 911. Further purification was conducted by HPLC with a DEAE-5PW column. The eluate could be divided into four peak fractions based on the absorbance at 417 nm, although each fraction was not clearly separated. Among these fractions, immunoreactive protein with the antibody against P450GPF-B was mainly eluted in the pass-through fraction. We carried out further purification of the pass-through fraction by hydroxylapatite and CM-Sphadex C50 column chromatographies, and two P450 enzymes, called P450JM-D and P450JM-E were isolated, although P450JM-D did not react with antibody against P450GPF-B (data not shown). The purified P450s showed a single protein band on SDS-PAGE, and the apparent molecular weights of P450JM-D and P450JM-E were estimated to be 52200 and 51800, respectively (Fig. 4) . Both of the purified P450s had a specific content of 12.2 nmol/mg protein. The first 18 residues of the NH 2 
were the same as those of P450CMLd, which is an enzyme belonging to the CYP2C subfamily purified from hepatic microsomes of cynomolgus monkeys.
35) The NH 2 -terminal amino acid sequence of 
Catalytic Properties of Purified P450
In the reconstituted system, we used a microsomal lipid system including cytochrome b 5 and sodium cholate as described previously. 10) The oxidative activities of 7a-and 7b-OH-D 8 -THC to 7-Oxo-D 8 -THC by P450JM-E were 1.11 and 6.33 nmol/min/ nmol P450, respectively (Table 2 ). P450JM-E was also able to oxidize both 8a-and 8b-OH- To lane 1 were applied standard proteins consisting of bovine serum albumin (molecular mass, 66000), egg albumin (45000), glyceraldehyde-3-phosphate dehydrogenase (36000), carbonic anhydrase (29000), and trypsinogen (24000). Lanes 2, 3, and 4 contained 20 mg of hepatic microsomes of Japanese female monkey and 1.0 mg of P450JM-D and P450JM-E, respectively. D was less than 10% of that of P450JM-E. P450JM-E also showed high testosterone 6b-hydroxylase activity (9.21 nmol/min/nmol P450) in the reconstituted system. On the other hand, the androstendione-forming activity of P450JM-D was more than 10-fold higher than that of P450JM-E.
Incorporation of Atmospheric Oxygen into 7-Oxo-D D
-THC and 8-Oxo-D D
9
-THC 7-OH-D 8 -THC and 8-OH-D 9 -THC were incubated with P450JM-E under an 18 O 2 gas phase, and the trimethylsilyl derivative of the metabolites was analyzed by GC-MS. -THC were 0.14 and 0.81, and 18 O was incorporated into 3% and 35%, respectively.
DISCUSSION
In the course of our metabolic studies on THC, we have found that oxidation at the C7-position of D 8 -THC is a major metabolic pathway in hepatic microsomes of the guinea pig and that the oxidation of 7-OH-D 8 -THC to 7-Oxo-D 8 -THC may be catalyzed by P450, not dehydrogenase. 9, 10) We have also found that antibody against P450GPF-B purified from hepatic microsomes of guinea pigs as a major enzyme responsible for 7-OH-D 8 -THC MALCO also inhibited MALCO activity in mouse, rat, monkey, and human livers. 10) This result suggested that the protein immunochemically related to P450GPF-B might be the principal enzyme involved in MALCO in various animal species.
We have previously reported that the MALCO activity for 7-OH-D 8 -THC is stereoselective and the formation of 7-Oxo-D 8 -THC from 7b-OH-D 8 -THC in guinea pigs, 10) mice, 11) rats, 12) and humans 13) is 1.9-, 2.0-, 3.0-, and 4.5-fold, respectively, higher than that from 7a-OH-D 8 -THC. In the present study, the same stereoselectivity was also shown in hepatic microsomes of monkeys, and the MALCO activity for 7b-OH-D 8 -THC was about 4-fold higher than that for 7a-OH-D 8 -THC. These results indicate that there is a species-related difference in the extent of stereoselectivity for the substrate.
Testosterone 6b-hydroxylase is thought to be one of specific reactions for the CYP3A enzyme in monkey liver. 37, 38) The MALCO activity for 7-OH-D 8 -THC as well as testosterone 6b-hydroxylase activity was inhibited dose-dependently by antibody against P450GPF-B. Furthermore, in the Lineweaver-Burk double-reciprocal plot analysis, testosterone 6b-hydroxylase was competitively inhibited by the addition of 7b-OH-D 8 -THC to the incubation mixture. These results suggest that the major enzyme of MALCO in monkey liver is P450 belonging to the 3A subfamily. 7a-OH-D 8 -THC MALCO activity, however, may be also catalyzed by other P450 enzymes together with CYP3A, since the activity inhibited by antibody against P450GPF-B was up to 35% of the control value. We purified two P450 enzymes, called P450JM-D and P450JM-E, from hepatic microsomes of Japanese monkeys. P450JM-E is assumed to be CYP3A8 and showed high forming activity of 7-Oxo-D 8 -THC from 7a-and 7b-OH-D 8 -THC. On the other hand, the 7-Oxo-D 8 -THC forming activity of P450JM-D was relatively low compared with that of P450JM-E. The testosterone 6b-hydroxylase activity of P450JM-E is considerablely higher than that of CYP3A8 (P450CMLc) purified from hepatic microsomes of cynomolgus monkey as reported by Ohmori et al. 37) The reason may be attributable to the use of microsomal lipids instead of dilauroylphosphatidylcholine as the lipid in the reconstituted system of P450JM-E, because a number of studies have shown that the catalytic activities of CYP3A enzymes are very low in a reconstituted system using only dilauroylphosphatidylcholine as the lipid. 17, [39] [40] [41] P450JM-E showed comparable activity to CYP3A1, 40) CYP3A4, 41) and CYP3A11 11) for testosterone 6b-hydroxylase. In the reconstituted system of P450JM-E, the MALCO activity for 7b-OH-D 8 -THC was about 6-fold higher than that for 7a-OH-D 8 -THC. In our previous investigation, the formation of 7-Oxo-D 11) and humans 13) was 1.7-, 1.9-, and 3.4-fold, respectively, higher than that from 7a-OH-D 8 -THC. The stereoselectivity was consistent with the results using hepatic microsomes as described above. It is suggested that stereoselectivity for the substrates characterize the major P450 enzymes responsible for the formation of 7-Oxo-D O 2 , 7-Oxo-D 8 -THC formed was converted to the trimethylsilyl derivative and analyzed at an ionization energy of 70 eV on a JEOL DX-300 mass spectrometer.
